Kewajiban jangka dawa marang ekuitas: Orthofix Corp (OFIX)

Simbol resmi perusahaan Orthofix Corp (OFIX)

The market valuation chart for Orthofix Medical Inc. (OFIX) on the GURU.Markets platform illustrates a business whose bone stimulators and spinal systems have reached maturity, with current growth driven by integration processes. The current metric stands at 0.61. Profitability is tied to the volume of scheduled procedures, synergies with SeaSpine, and margins on consumables. Patent protection, FDA certification, and extensive physician training create high barriers to entry.

Orthofix International (OFIX): Utang jangka dawa marang modal saka 04.07.2022 nganti 28.10.2026
Barang utama Orthofix Medical Inc.

When constructing a long-term portfolio, screening focuses on the stability of the financing structure via the ratio of liabilities with a maturity of over one year to equity. This metric measures the business's dependence on external borrowing, which for Orthofix Medical Inc. (OFIX) and its diversified implant portfolio signifies a balance between expansion and solvency, as clearly reflected by the long-term debt-to-equity history on GURU.Markets.

Pesaing langsung

Rasio tanggungan utang jangka dawa marang modal BSX|EW - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang ekuitas ResMed Corporation (RMD)|PODD: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Zimmer ZBH|COO: Utang jangka dawa marang modal|ALGN - Rasio utang jangka dawa marang ekuitas|Globus Medical Corp - Utang jangka dawa marang modal|TransMedics Group, Inc. (TMDX) - Rasio tanggungan utang jangka dawa marang modal|ATEC (Alphatec Holdings, Inc.) - Utang jangka dawa marang modal|Utang jangka dawa marang modal AORT|Utang jangka dawa marang ekuitas Enovis (ENOV)|Utang jangka dawa marang ekuitas Integra LifeSciences Corp (IART)|Utang jangka dawa marang modal ESTA|BBNX - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas IRADIMED CORPORATION|EMBC - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang modal TNDM|AxoGen Inc (AXGN) - Kewajiban jangka dawa marang modal|Utang jangka dawa marang modal SI-BONE Corp (SIBN)|Rasio utang jangka dawa marang modal Bioventus Global (BVS)|OrthoPediatrics Corp. (KIDS) - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal TMCI (treace.com)|Strata Critical Medical - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas Carlsmed, Inc. CARL|RXST (RxSight Corp) - Utang jangka dawa marang modal|CLPT - Kewajiban jangka dawa marang modal|Utang jangka dawa marang modal Stereotaxis, Inc.|neurostar.com (STIM) - Rasio utang jangka dawa marang modal|SGHT: Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal Orchestra BioMed Inc.|Utang jangka dawa marang modal ANIK (Anika Therapeutics)|Rasio utang jangka dawa marang ekuitas InspireMD Inc. (NSPR)|Utang jangka dawa marang modal ZJYL (Jin Medical)|Vivani Medical Inc - Utang jangka dawa marang modal|XTNT - Utang jangka dawa marang ekuitas|NeuroOne (NMTC) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas modular-medical.com MODD|Myomo Inc (MYO) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal COCH (Envoy Medical, Inc.)|Kewajiban jangka dawa marang modal VVOS|NVNO: Utang jangka dawa marang ekuitas|Tanggungan utang jangka dawa marang ekuitas sintx.com SINT|Rasio utang jangka dawa marang ekuitas TNON (Tenon Medical, Inc)|Utang jangka dawa marang modal Lifeward Ltd. LFWD|Utang jangka dawa marang modal AMIX (Autonomix)|IVF: Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Bone Biologics Corp (BBLG)|AXNX (Axonics Inc.) - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang ekuitas BIOL|Rasio utang jangka dawa marang ekuitas Dynatronics Corp.|Paragon 28, Inc. - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal INVO (invobioscience.com)